Wnt pathway regulation may play a role in this lack of response, as tumor-intrinsic, active β-catenin signaling in human melanoma has been associated with resistance to anti-CTLA4 and anti-PD-L1 antibodies due to T cell exclusion [88]. Here, CTLA4 is linked to neoplasm.